Sakr WA[Author] - Search Results

Year	Number of Results
1987	1
1989	2
1990	3
1991	1
1992	3
1993	6
1994	6
1995	3
1996	6
1997	5
1998	7
1999	6
2000	8
2001	6
2002	3
2003	2
2004	6
2005	1
2006	1
2007	4
2008	2
2009	1
2010	2
2011	4
2012	4
2013	4
2014	1
2015	1
2016	2
2017	2
2018	3
2019	3
2020	2
2022	2
2023	1
2024	0

1

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Al-Sarraf M, et al. Among authors: sakr wa. J Clin Oncol. 1998 Apr;16(4):1310-7. doi: 10.1200/JCO.1998.16.4.1310. J Clin Oncol. 1998. PMID: 9552031 Corrected and republished. Clinical Trial.

2

The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin.

Sheng S, Bernardo M, Dzinic SH, Chen K, Sakr WA. Sheng S, et al. Among authors: sakr wa. Cancer Metastasis Rev. 2022 Dec;41(4):965-974. doi: 10.1007/s10555-022-10070-2. Epub 2022 Dec 1. Cancer Metastasis Rev. 2022. PMID: 36451067 Free PMC article. Review.

3

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF. Al-Sarraf M, et al. Among authors: sakr wa. J Clin Oncol. 2023 Aug 20;41(24):3965-3972. doi: 10.1200/JCO.22.02764. J Clin Oncol. 2023. PMID: 37586209

4

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.

Sheng S, Margarida Bernardo M, Dzinic SH, Chen K, Heath EI, Sakr WA. Sheng S, et al. Among authors: sakr wa. Cancer Metastasis Rev. 2018 Dec;37(4):655-663. doi: 10.1007/s10555-018-9767-4. Cancer Metastasis Rev. 2018. PMID: 30484007 Free PMC article. Review.

5

Epidemiology of prostate cancer.

Haas GP, Sakr WA. Haas GP, et al. Among authors: sakr wa. CA Cancer J Clin. 1997 Sep-Oct;47(5):273-87. doi: 10.3322/canjclin.47.5.273. CA Cancer J Clin. 1997. PMID: 9314822 Free article. Review.

6

Prevention of prostate cancer.

Schulman CC, Zlotta AR, Denis L, Schröder FH, Sakr WA. Schulman CC, et al. Among authors: sakr wa. Scand J Urol Nephrol Suppl. 2000;(205):50-61. doi: 10.1080/003655900750169301. Scand J Urol Nephrol Suppl. 2000. PMID: 11144904 Review.

7

Age and racial distribution of prostatic intraepithelial neoplasia.

Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Sakr WA, et al. Eur Urol. 1996;30(2):138-44. doi: 10.1159/000474163. Eur Urol. 1996. PMID: 8875194 Review.

8

Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens.

Sakr WA, Grignon DJ. Sakr WA, et al. Urol Clin North Am. 1999 Aug;26(3):453-63, v. doi: 10.1016/s0094-0143(05)70194-4. Urol Clin North Am. 1999. PMID: 10494284 Review.

9

Cellular and molecular pathology of prostate cancer precursors.

Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der Kwast T, Montironi R, Sakr WA. Foster CS, et al. Among authors: sakr wa. Scand J Urol Nephrol Suppl. 2000;(205):19-43. doi: 10.1080/003655900750169284. Scand J Urol Nephrol Suppl. 2000. PMID: 11144897 Review.

10

Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.

Sakr WA, Partin AW. Sakr WA, et al. Urology. 2001 Apr;57(4 Suppl 1):115-20. doi: 10.1016/s0090-4295(00)00953-5. Urology. 2001. PMID: 11295607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year